Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Cephalalgia : an International Journal of Headache
|
May 28, 2025
Longitudinal analysis of pain-induced brain activations in post-traumatic headache
Dohyun Ku, Lingchao Mao, Simona Nikolova, et al.
Journal of Medicinal Chemistry
|
February 13, 2008
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists
Takashi Yamamoto, Padma Nair, Josef Vagner, et al.
Research Square
|
September 18, 2025
Symptoms of Allodynia and Pain Thresholds Amongst Those with Acute Post-Traumatic Headache Attributed to Mild Traumatic Brain Injury: A Prospective, Longitudinal Study
Noah Ziff, Gina Dumkrieger, Santiago Garza, et al.
The Journal of Headache and Pain
|
November 29, 2025
Symptoms of allodynia and pain thresholds amongst those with acute post-traumatic headache attributed to mild traumatic brain injury: a prospective, longitudinal study
Noah Ziff, Gina Dumkrieger, Santiago Garza, et al.
Mabs
|
September 12, 2023
Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders
Stephanie Maciuba, Gregory D Bowden, Harrison J Stratton, et al.
Science Translational Medicine
|
February 7, 2020
The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females
Yanxia Chen, Aubin Moutal, Edita Navratilova, et al.
Molecular Pain
|
January 24, 2018
Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer
Moe Watanabe, Michiko Narita, Yusuke Hamada, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 29, 2004
Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides
Nura O Elmagbari, Richard D Egleton, Michael M Palian, et al.
Cephalalgia : an International Journal of Headache
|
April 6, 2017
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention
Jennifer Y Xie, Milena De Felice, Caroline M Kopruszinski, et al.
Brain : a Journal of Neurology
|
March 4, 2025
Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PAR2, in preclinical models of migraine
Caroline M Kopruszinski, John E Linley, Peter Thornton, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Cephalalgia : an International Journal of Headache
|
May 28, 2025
Longitudinal analysis of pain-induced brain activations in post-traumatic headache
Dohyun Ku, Lingchao Mao, Simona Nikolova, et al.
Journal of Medicinal Chemistry
|
February 13, 2008
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists
Takashi Yamamoto, Padma Nair, Josef Vagner, et al.
Research Square
|
September 18, 2025
Symptoms of Allodynia and Pain Thresholds Amongst Those with Acute Post-Traumatic Headache Attributed to Mild Traumatic Brain Injury: A Prospective, Longitudinal Study
Noah Ziff, Gina Dumkrieger, Santiago Garza, et al.
The Journal of Headache and Pain
|
November 29, 2025
Symptoms of allodynia and pain thresholds amongst those with acute post-traumatic headache attributed to mild traumatic brain injury: a prospective, longitudinal study
Noah Ziff, Gina Dumkrieger, Santiago Garza, et al.
Mabs
|
September 12, 2023
Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders
Stephanie Maciuba, Gregory D Bowden, Harrison J Stratton, et al.
Science Translational Medicine
|
February 7, 2020
The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females
Yanxia Chen, Aubin Moutal, Edita Navratilova, et al.
Molecular Pain
|
January 24, 2018
Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer
Moe Watanabe, Michiko Narita, Yusuke Hamada, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 29, 2004
Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides
Nura O Elmagbari, Richard D Egleton, Michael M Palian, et al.
Cephalalgia : an International Journal of Headache
|
April 6, 2017
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention
Jennifer Y Xie, Milena De Felice, Caroline M Kopruszinski, et al.
Brain : a Journal of Neurology
|
March 4, 2025
Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PAR2, in preclinical models of migraine
Caroline M Kopruszinski, John E Linley, Peter Thornton, et al.
Page
of 11